0 items USD 0.00Search
Your search for "delveinsight diabetic peripheral neuropathy pipeline insights 2015" gave back 56 results.
The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of...
Catalog:
La Merie Publishing
November 2014
Price: USD 499.00
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis...
Catalog:
La Merie Publishing
November 2014
Price: USD 381.00
The present Competitive Intelligence Report about alpha1-proteinase inhibitors (alpha1-PI), alpha1-antitrypsin (AAT) and elastase inhibitors provides...
Catalog:
La Merie Publishing
July 2014
Price: USD 272.00
The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and...
Catalog:
iGATE
October 2016
Price: USD 1,350.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field...
Catalog:
La Merie Publishing
April 2015
Price: USD 1,500.00
“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CKD. The...
Catalog:
IQ4I
May 2015
Price: USD 3,600.00
“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The...
Catalog:
IQ4I
May 2015
Price: USD 3,600.00
The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in...
Catalog:
La Merie Publishing
October 2015
Price: USD 345.00
The Competitive Intelligence report about sphingosine-1-phosphate (S1P) receptor modulators provides a competitor analysis of approved or novel S1P...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
The Competitive Intelligence report about inhibitors of interleukin-4 (IL-4) and/or IL-13 and antagonists of the IL-4 or IL-13 receptor provides a...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
The Competitive Intelligence report about Interleukin-23 (IL-23) and IL-12/23 antagonists provides a competitor analysis of approved or being...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast...
Catalog:
Rockville Research
April 2019
Price: USD 1,100.00
“ IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS ” gives comprehensive insights on the various Immune Checkpoint modulators...
Catalog:
IQ4I
April 2016
Price: USD 4,500.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
